HOUSTON, TEXAS / ACCESS Newswire / October 1, 2025 / XCF Global, Inc. (“XCF”) (Nasdaq:SAFX), a key player in decarbonizing ...
The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results